Ascend is set to become a state-of-the-art oral solid dosage (OSD) manufacturing hub, poised to capitalize on Ethiopia’s pharmaceutical market.
The plant has already secured a temporary license from the Ethiopian Food and Drug Administration to produce stability batches, a crucial step towards obtaining final GMP certification.
Ascend
- Africa
- Listing ID :
- 2215
- Asking Price :
![](https://dealweaver.net/wp-content/uploads/2025/01/pexels-pixabay-139398-1024x682.jpg)
Business Overview
Financial
Geography |
---|
Africa |
Investment |
---|
100% Sale to Strategic Buyer |
Industry |
---|
Pharmacuetical Manufacturing |
Financials |
---|
Revenue |
EBIDTA |
Mar-2024 |
---|
N/A |
N/A |
March 2025 Projected |
---|
N/A |
N/A |
2026 Projected |
---|
$ 6 mn |
N/A |